Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,096,871
+$12,281,387 QoQ
Shares Held
400,245
+20.9% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#70
of 477 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GILDER GAGNON HOWE & CO LLC holds $353,222,516 across 21 Biotechnology names. CYTK ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
269,051 | $80,992,422 | |
| 2 | NKTR |
Nektar Therapeutics
|
600,873 | $41,946,944 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
548,926 | $40,884,008 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,313,211 | $34,432,392 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
400,245 | $34,096,871 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
229,053 | $26,265,507 | |
| 7 | QURE |
uniQure N.V.
|
530,979 | $24,456,892 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
28,573 | $15,342,272 |
All Filings in CYTK
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,096,871 | 400,245 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,815,484 | 330,989 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,515,002 | 385,820 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,382,462 | 389,055 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,314,439 | 191,115 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $597,303 | 14,862 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $559,399 | 11,892 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $715,704 | 13,555 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $749,309 | 13,830 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $985,115 | 14,051 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,199,544 | 26,345 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $781,662 | 26,533 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $863,255 | 26,464 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $944,394 | 26,837 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,251,802 | 27,320 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,251,705 | 25,835 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||